Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.35 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.34 |
| ▸ | METAP2 | P50579 | 2/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.32 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22157021 | 0.96 | CYP11B2 (0.33) | CLK4CYP11B2METAP2ADORA2BCYP11B1 | |
| SCHEMBL22156391 | 0.92 | CLK4 (0.35) | CLK4CYP11B2METAP2ADORA2BCYP11B1 | |
| SCHEMBL22157196 | 0.91 | CLK4 (0.35) | CLK4CYP11B2ADORA2BCYP11B1NR3C1 | |
| SCHEMBL22156569 | 0.90 | CLK4 (0.37) | CLK4CYP11B2METAP2CYP11B1 | |
| SCHEMBL22157019 | 0.89 | CYP11B2 (0.33) | CLK4CYP11B2ADORA2BCYP11B1NR3C1 | |
| SCHEMBL22156387 | 0.89 | CYP11B2 (0.33) | CLK4CYP11B2METAP2ADORA2BCYP11B1 | |
| SCHEMBL22156567 | 0.88 | ALDH1A1 (0.36) | CLK4CYP11B2CYP11B1NR3C1 | |
| SCHEMBL22158502 | 0.86 | SCN9A (0.38) | CLK4CYP11B2METAP2 | |
| SCHEMBL22157142 | 0.86 | CYP11B2 (0.35) | CLK4CYP11B2METAP2CYP11B1 | |
| SCHEMBL22157121 | 0.85 | CYP11B1 (0.38) | CYP11B2CYP11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200203628-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, OR51E2 | CLK4 3423/4885CYP11B2 531/4885METAP2 3763/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.